Archean Chemical Q1FY27 revenue rises 11% to ₹3,328M on Bromine surge
Archean Chemical Industries' Q1FY27 results show robust top-line growth of 11% to ₹3,328 million, led by a 58% increase in Bromine revenues. Despite a 12% decline in Industrial Salt due to logistical challenges, the company achieved operational breakthroughs, including EBITDA positivity in Acume Chemicals and the inauguration of a UK-based battery pilot plant.
*this image is generated using AI for illustrative purposes only.
Archean Chemical Industries reported an 11% year-on-year rise in Q1FY27 total revenue to ₹3,328 million, driven by a sharp recovery in its Bromine segment and improving product mix. The top-line growth contrasts with the previous quarter’s margin pressures, as the company navigated logistical challenges in its core Industrial Salt business while achieving operational milestones in newer ventures like Acume Chemicals and Offgrid Energy Labs.
Segment Performance Breakdown
The revenue growth was primarily fueled by the Bromine segment, which saw revenues surge by 58% year-on-year to ₹1,333 million. This increase was supported by firmer realisations and steadily improving throughput, with volumes reaching 4,175 tons. In contrast, the Industrial Salt segment faced headwinds, with revenue de-growing by 12% to ₹1,713 million. Volumes for Industrial Salt stood at 0.98 million tons, impacted by logistics and transportation challenges, including higher transit times and elevated freight costs due to conflicts in West Asia.
| Segment | Revenue (₹ Mn) | YoY Change | Key Drivers |
|---|---|---|---|
| Bromine | 1,333 | +58% | Firmer realisations, improved throughput |
| Industrial Salt | 1,713 | -12% | Logistics challenges, freight cost pressures |
| Bromine Derivatives | 296 | +28% | Organic bromides, new product launches |
| SOP | 113 | N/A | Maintaining business momentum |
New Ventures and Strategic Initiatives
Archean’s Bromine Derivatives business, operated through Acume Chemicals, grew by 28% in Q1FY27 to ₹296 million, led by organic bromides. Notably, this segment turned EBITDA-positive at ₹19 million during the quarter, compared to an EBITDA loss of ₹27 million in Q1FY26, thanks to improved capacity utilization. The company has launched new products and is developing additional compounds on a campaign basis.
In the energy storage space, Offgrid Energy Labs inaugurated its first Zinc Bromide-based battery (ZincGel®) pilot manufacturing facility in Hook, Hampshire, United Kingdom. This 10 MWh demonstration line marks the transition from laboratory innovation to commercial pilot-scale production, laying the foundation for a future gigafactory in India. The initiative leverages Archean’s bromine business synergy, as Zinc Bromide batteries use zinc-bromide chemistry.
Semiconductor and Mud Chemicals Progress
Archean continues to advance its semiconductor strategy through SiCSem Private Limited, which received approval under the Indian Semiconductor Mission (ISM) for India’s first Silicon Carbide (SiC) based semiconductor fab and packaging unit. An IIT Bhubaneswar developmental lab worth ₹65 crore is being established within the facility to deepen academia-industry linkages.
Meanwhile, Idealis Mudchemie (formerly Oren Hydrocarbon) is focusing on operationalizing its plants. Although refurbishment activities and regulatory approvals delayed commercialization, three plants have been successfully commissioned, with customer trials progressing and some orders received.
What the Numbers Show
The divergence between the Industrial Salt and Bromine segments highlights Archean’s shifting revenue dynamics. While the traditional salt business faces cyclical logistical pressures, the high-margin Bromine segment is driving significant growth. The turnaround in Acume Chemicals’ EBITDA signals that capacity utilization improvements are beginning to yield financial results, reducing reliance on the core salt business for profitability. However, the overall impact on net profit will depend on how quickly these higher-margin segments can offset the volume declines in salt.
Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE128X01021/6747a186-51fc-4b72-b872-00e92014850d.pdf
Historical Stock Returns for Archean Chemical Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -6.33% | -5.01% | +0.64% | -7.14% | -19.44% | +14.73% |
How might the resolution of West Asian conflicts impact freight costs and volume recovery for Archean's Industrial Salt segment in the coming quarters?
What is the projected timeline for Archean to achieve full commercial scale production at its UK ZincGel® pilot facility and subsequent gigafactory in India?
To what extent will the EBITDA-positive performance of Acume Chemicals accelerate, and can it fully offset the margin pressures from the declining salt business by FY27 end?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
